Bioprocessing

 

The bioprocessing track provides a technical forum for biopharmaceutical development, bioprocessing and manufacturing strategies. 

It includes downstream processing, addressing key issues in continuous processing, single-use technology, chromatography, automation and analytics to make the purification of biologics more efficient and cost effective.

 

Key Speakers:

Bo Kara, Head Process Development, Advanced Therapy Delivery, GSK

Bo Kara, Head Process Development, Advanced Therapy Delivery, GSK

Otto-Wilhelm Merten, Head of the Applied Vectorology and Innovation Group, Généthon

Otto-Wilhelm Merten, Head of the Applied Vectorology and Innovation Group, Généthon

Nicolas Urbieta, USP Scientist, Sanofi

Nicolas Urbieta, USP Scientist, Sanofi

Katy Spink, Chief Operating Officer, Asterias Biotherapeutics

Katy Spink, Chief Operating Officer, Asterias Biotherapeutics  

James Leverone, Head of Process Engineering and Validation, ImmunoGen

James Leverone, Head of Process Engineering and Validation, ImmunoGen

Dylan Jones, Principal Scientist, Genzyme

Dylan Jones, Principal Scientist, Genzyme

Manuel Carrondo, Professor of Chemical & Biochemical Engineering, FCT-UNL, Vice-President, IBET

Manuel Carrondo, Professor of Chemical & Biochemical Engineering, FCT-UNL, Vice-President, IBET

Qasim Rafiq, Senior Lecturer (Associate Professor), Bioprocessing of Regenerative, Cellular and Gene Therapies, Department of Biochemical Engineering, UCL

Qasim Rafiq, Senior Lecturer (Associate Professor), Bioprocessing of Regenerative, Cellular and Gene Therapies, Department of Biochemical Engineering, UCL  

 

SEE MORE SPEAKERS

 

Key Topics:

  • Process Development & Manufacturing – Gene Therapy
  • Continuous manufacturing: drivers and critical enablers
  • Process Development & Manufacturing – Gene Therapy
  • Downstream Bioprocessing
  • Process Development & Manufacturing
  • Supply Chain Management

 

Part of:

World Advanced Therapies and Regenerative Medicine Congress

The World Advanced Therapies and Regenerative Medicine Congress looks at the precision medicine pipeline, from early discovery and development of drugs and diagnostics, through to implementation in clinics and hospitals.

Ethics, regulations and patient advocacy and involvement is also explored, with talks, roundtables and panels being run by top senior executives, clinicians, academics and thought leaders.

With the new addition of AI in Healthcare, the congress is expanding to include some of the most exciting uses of technology for genomic medicine, patient management and data handling.

 

DOWNLOAD BROCHURE

 

Sign Up for Event Updates

World Precision Medicine Congress

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com